Decreased histone deacetylase activity in COPD Source: Annual Congress 2008 - Epigenetic modifications in lung disease Year: 2008
Histone deacetylase activity is reduced in COPD. Modulation by theophylline Source: Eur Respir J 2003; 22: Suppl. 45, 4s Year: 2003
Histone acetylation and deacetylation: importance in inflammatory lung diseases Source: Eur Respir J 2005; 25: 552-563 Year: 2005
Steroids and histone deacetylase in ventilation-induced gene transcription Source: Eur Respir J 2007; 30: 865-877 Year: 2007
Histone deacetylases (HDACs) and lung disease Source: Annual Congress 2011 - Why is epigenetics important for lung disease? Year: 2011
Expression of histone deacetylases (HDAC3) and phosporylated-cAMP response element-binding (P-CREB) in bronchial biopsies of asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 470s Year: 2004
Levels of histone deacetylace (HDAC) activity in induced sputum of smokers, non smokers and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 129s Year: 2005
The role of histone deacetylase 9 in the imbalance of Th17/Treg in bronchial asthma Source: Annual Congress 2012 - Mechanisms of asthma Year: 2012
Global histone H3 lysine 4 (H3K4) dimethylation is an important prognostic factor in lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
Differential modification in the generation of IL-8 and GM-CSF by p38MAPK, MKK-1 and histone deacetylase activity in IL-1[β]-stimulated human monocytes from non-smokers, smokers and patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 87s Year: 2002
microRNA-223 suppresses histone deacetylase 2 in chronic obstructive pulmonary disease Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015
IL-1β induced histone H3-K4 tri-methylation and RNA polymerase II recruitment to the SLPI gene Source: Eur Respir J 2005; 26: Suppl. 49, 556s Year: 2005
Low-dose theophylline improves lung inflammatory profile during COPD exacerbations by increasing histone deacetylase activity Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008
Comparison of anticancer effects of a novel histone deacetylase (HDAC) inhibitor CG200745 and SAHA in non-small lung cancer cells Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer Year: 2019
The role of histone deacetylase 2 (HDAC2) and glucocorticoid receptor (GR) isoforms α, β in patients with asthma–COPD overlap syndrome (ACOS) Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016
The effects of dexamethasone and IL-1β on histone H3 methylation in A549 cells Source: Eur Respir J 2003; 22: Suppl. 45, 224s Year: 2003
Histone deacetylases reduction causes defect of Nrf2 response, leading to a reduction of anti-oxidant capacity in COPD Source: Annual Congress 2010 - Pathology and immunology of COPD Year: 2010
Citrullinated histone H3 is increased in blood of asthma subjects Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019
Effect of cigarette smoke extract (CSE) on histone acetylation of lung fibroblasts in vitro compared to histone acetylation in patients with lung emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 583s Year: 2006